SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000863894-23-000012
Filing Date
2023-11-15
Accepted
2023-11-15 16:54:47
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A veru-20230630x10qa.htm   iXBRL 10-Q/A 3482241
2 EX-31.1 veru-20230630xex31_1.htm EX-31.1 16003
3 EX-31.2 veru-20230630xex31_2.htm EX-31.2 16340
4 EX-32.1 veru-20230630xex32_1.htm EX-32.1 12460
  Complete submission text file 0000863894-23-000012.txt   13498858

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20230630.xsd EX-101.SCH 66830
6 EX-101.CAL veru-20230630_cal.xml EX-101.CAL 75273
7 EX-101.DEF veru-20230630_def.xml EX-101.DEF 252483
8 EX-101.LAB veru-20230630_lab.xml EX-101.LAB 476022
9 EX-101.PRE veru-20230630_pre.xml EX-101.PRE 434603
77 EXTRACTED XBRL INSTANCE DOCUMENT veru-20230630x10qa_htm.xml XML 3141172
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-13602 | Film No.: 231411281
SIC: 2834 Pharmaceutical Preparations